These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34527736)

  • 1. The Challenge of Using an Antigen Test as a Screening Tool for SARS-CoV-2 Infection in an Emergency Department: Experience of a Tertiary Care Hospital in Southern Italy.
    Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Casulli D; Accogli M; Chironna M
    Biomed Res Int; 2021; 2021():3893733. PubMed ID: 34527736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
    Mueller T; Kompatscher J; La Guardia M
    J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
    Orsi A; Pennati BM; Bruzzone B; Ricucci V; Ferone D; Barbera P; Arboscello E; Dentone C; Icardi G
    J Virol Methods; 2021 Sep; 295():114201. PubMed ID: 34058287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
    Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
    Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CLINITEST® Rapid Covid-19 + Influenza antigen test in a cohort of symptomatic patients in an emergency department.
    Maldonado-Barrueco A; Gutiérrez-Arroyo A; Bloise I; de Ceano-Vivas M; Rivera-Nuñez A; Santos-Olmos RT; Vega DM; García-Rodríguez J;
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):853-861. PubMed ID: 38421466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings.
    Thakur P; Saxena S; Manchanda V; Rana N; Goel R; Arora R
    Lab Med; 2021 Nov; 52(6):e154-e158. PubMed ID: 33928384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the field performance of multiple SARS-Cov-2 antigen rapid tests using nasopharyngeal swab samples.
    Nóra M; Déri D; Veres DS; Kis Z; Barcsay E; Pályi B
    PLoS One; 2022; 17(2):e0262399. PubMed ID: 35157700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020.
    Brihn A; Chang J; OYong K; Balter S; Terashita D; Rubin Z; Yeganeh N
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):702-706. PubMed ID: 33983916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?
    Cento V; Renica S; Matarazzo E; Antonello M; Colagrossi L; Di Ruscio F; Pani A; Fanti D; Vismara C; Puoti M; Scaglione F; Perno CF; Alteri C; On Behalf Of The S Co Va Study Group
    Viruses; 2021 May; 13(5):. PubMed ID: 34062916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.
    Albert E; Torres I; Bueno F; Huntley D; Molla E; Fernández-Fuentes MÁ; Martínez M; Poujois S; Forqué L; Valdivia A; Solano de la Asunción C; Ferrer J; Colomina J; Navarro D
    Clin Microbiol Infect; 2021 Mar; 27(3):472.e7-472.e10. PubMed ID: 33189872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
    Linares M; Pérez-Tanoira R; Carrero A; Romanyk J; Pérez-García F; Gómez-Herruz P; Arroyo T; Cuadros J
    J Clin Virol; 2020 Dec; 133():104659. PubMed ID: 33160179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
    Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
    Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
    Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.
    Courtellemont L; Guinard J; Guillaume C; Giaché S; Rzepecki V; Seve A; Gubavu C; Baud K; Le Helloco C; Cassuto GN; Pialoux G; Hocqueloux L; Prazuck T
    J Med Virol; 2021 May; 93(5):3152-3157. PubMed ID: 33615487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.